Initial Management of Supraventricular Tachycardia
For hemodynamically stable SVT patients, begin with vagal maneuvers immediately, followed by intravenous adenosine if unsuccessful, while hemodynamically unstable patients require immediate synchronized cardioversion. 1, 2
Immediate Assessment: Hemodynamic Stability
Determine hemodynamic stability first - this dictates your entire management pathway. Unstable patients present with altered mental status, hypotension, acute heart failure, or ongoing chest pain indicating ischemia. 1
For Hemodynamically Unstable Patients
- Perform synchronized cardioversion immediately if vagal maneuvers and adenosine fail or are not feasible - this is a Class I recommendation with proven safety and effectiveness. 1
- Do not delay cardioversion attempting multiple pharmacologic agents in unstable patients. 1
For Hemodynamically Stable Patients
Step 1: Vagal Maneuvers (First-Line)
- Attempt vagal maneuvers first - these are Class I recommended initial interventions with a 27.7% overall success rate when switching between techniques. 1, 2
Specific techniques to employ:
- Modified Valsalva maneuver (most effective): Patient bears down against a closed glottis for 10-30 seconds in the supine position, generating at least 30-40 mm Hg intrathoracic pressure - this achieves 43% effectiveness. 1, 2, 3
- Carotid sinus massage: Apply steady pressure over the right or left carotid sinus for 5-10 seconds, but only after confirming absence of carotid bruits by auscultation. 1, 2
- Diving reflex: Apply an ice-cold, wet towel to the face or facial immersion in 10°C water. 1, 2
Critical pitfall to avoid: Never apply pressure to the eyeball - this practice is dangerous and has been abandoned. 1, 2
Step 2: Adenosine (First-Line Pharmacotherapy)
- Administer intravenous adenosine if vagal maneuvers fail - this is a Class I recommendation with 91-95% effectiveness for terminating AVNRT. 1, 2, 3
- Adenosine serves dual purposes: therapeutic termination and diagnostic unmasking of atrial activity in flutter or atrial tachycardia. 1
Step 3: Alternative Pharmacologic Agents
If adenosine fails or is contraindicated, proceed with AV nodal blocking agents:
- Intravenous diltiazem or verapamil are particularly effective for converting AVNRT to sinus rhythm with 80-98% success rates - these are Class IIa recommendations. 1, 2
- Intravenous beta-blockers are reasonable alternatives with excellent safety profiles, though less effective than calcium channel blockers (Class IIa recommendation). 1, 2
Critical safety considerations before administering calcium channel blockers or beta-blockers:
- Confirm absence of ventricular tachycardia - these agents can cause hemodynamic collapse and ventricular fibrillation if given for VT or pre-excited atrial fibrillation. 1, 2
- Avoid in suspected systolic heart failure - calcium channel blockers and beta-blockers should not be used in patients with heart failure. 1
- Avoid in pre-excitation syndromes (Wolff-Parkinson-White) - AV nodal blocking agents may accelerate ventricular rate and precipitate ventricular fibrillation. 1, 2
Step 4: Refractory Cases
- Oral combination therapy with diltiazem plus propranolol may be reasonable when IV access is unavailable (Class IIb recommendation). 1
- Intravenous amiodarone may be considered when other therapies are ineffective or contraindicated (Class IIb recommendation). 1
- Synchronized cardioversion is recommended for stable patients when pharmacologic therapy fails or is contraindicated (Class I recommendation). 1
Special Population: Pre-Excited Atrial Fibrillation
This requires different management:
- Hemodynamically unstable: Immediate synchronized cardioversion (Class I). 2
- Hemodynamically stable: Intravenous ibutilide or procainamide (Class I recommendation). 2
- Never use AV nodal blockers (verapamil, diltiazem, beta-blockers, adenosine) - these can be lethal in pre-excited AF. 2
Post-Conversion Management
- Obtain 12-lead ECG in sinus rhythm to assess for pre-excitation (delta waves) and guide long-term management. 2, 4
- Refer all patients to cardiology for consideration of electrophysiology study and catheter ablation, which has 94.3-98.5% single-procedure success rates and is first-line therapy for preventing recurrence. 2, 3, 5
- Patient education on vagal maneuvers for self-termination of future episodes. 2